{"id":"https://openalex.org/W7225317898","doi":"https://doi.org/10.3324/haematol.2026.301971","title":"Depletion of CD19-positive B-cells and dexamethasone premedication may result in immune suppression in patients with B-precursor acute lymphoblastic leukemia after consolidation treatment with blinatumomab","display_name":"Depletion of CD19-positive B-cells and dexamethasone premedication may result in immune suppression in patients with B-precursor acute lymphoblastic leukemia after consolidation treatment with blinatumomab","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225317898","doi":"https://doi.org/10.3324/haematol.2026.301971","pmid":"https://pubmed.ncbi.nlm.nih.gov/42984405"},"language":"en","primary_location":{"id":"doi:10.3324/haematol.2026.301971","doi":"https://doi.org/10.3324/haematol.2026.301971","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2026.301971","pdf_url":"https://haematologica.org/article/download/14532/81121","source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://haematologica.org/article/download/14532/81121","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024202047","display_name":"Gerhard Zugmaier","orcid":"https://orcid.org/0000-0001-6879-2671","observed_orcids":["https://orcid.org/0000-0001-6879-2671"]},"institutions":[{"id":"https://openalex.org/I161103922","display_name":"Philipps University of Marburg","ror":"https://ror.org/01rdrb571","country_code":"DE","type":"education","lineage":["https://openalex.org/I161103922"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerhard Zugmaier","raw_affiliation_strings":["Department of Hematology, Oncology and Immunology, Philipps University of Marburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Oncology and Immunology, Philipps University of Marburg","institution_ids":["https://openalex.org/I161103922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035072666","display_name":"Nicola Goekbuget","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I4210132578","display_name":"University Hospital Frankfurt","ror":"https://ror.org/03f6n9m15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210132578"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nicola Goekbuget","raw_affiliation_strings":["Goethe University, University Medicine, Dept. of Medicine II, Hematology/Oncology, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Goethe University, University Medicine, Dept. of Medicine II, Hematology/Oncology, Frankfurt","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I4210132578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014838335","display_name":"Selina M. Luger","orcid":"https://orcid.org/0000-0003-3364-4366","observed_orcids":["https://orcid.org/0000-0003-3364-4366"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Selina Luger","raw_affiliation_strings":["Hematology-Oncology and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology-Oncology and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Litzow","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039583258","display_name":"Gunnar Cario","orcid":"https://orcid.org/0000-0001-8396-0127","observed_orcids":["https://orcid.org/0000-0001-8396-0127"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gunnar Cario","raw_affiliation_strings":["Department of Pediatric Oncology and Rheumatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology and Rheumatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022712318","display_name":"Franco Locatelli","orcid":"https://orcid.org/0000-0002-7976-3654","observed_orcids":["https://orcid.org/0000-0002-7976-3654"]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]},{"id":"https://openalex.org/I4210123352","display_name":"Bambino Ges\u00f9 Children's Hospital","ror":"https://ror.org/02sy42d13","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210123352","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Franco Locatelli","raw_affiliation_strings":["Department of Pediatric Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Catholic University of the Sacred Heart, Rome. franco.locatelli@opbg.net"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Ges\u00f9 Children's Hospital, Catholic University of the Sacred Heart, Rome. franco.locatelli@opbg.net","institution_ids":["https://openalex.org/I103320735","https://openalex.org/I4210123352"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2000,"currency":"EUR","value_usd":2157},"apc_paid":{"value":2000,"currency":"EUR","value_usd":2157},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.906000018119812},{"id":"https://openalex.org/keywords/b-cell-precursor-acute-lymphoblastic-leukemia","display_name":"B-cell precursor acute lymphoblastic leukemia","score":0.9210000038146973},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.621999979019165},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.703000009059906},{"id":"https://openalex.org/keywords/dexamethasone-premedication","display_name":"dexamethasone premedication","score":0.9459999799728394},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6930000185966492},{"id":"https://openalex.org/keywords/hypogammaglobulinemia","display_name":"hypogammaglobulinemia","score":0.9369999766349792},{"id":"https://openalex.org/keywords/immunoglobulin-replacement-therapy","display_name":"immunoglobulin replacement therapy","score":0.9520000219345093},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.6039999723434448},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.859000027179718},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8898000121116638},{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.8603000044822693},{"id":"https://openalex.org/C2778300832","wikidata":"https://www.wikidata.org/wiki/Q1589604","display_name":"Premedication","level":2,"score":0.5928999781608582},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.5619999766349792},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5468000173568726},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4603999853134155},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4490000009536743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4244000017642975},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.42289999127388},{"id":"https://openalex.org/C2779788671","wikidata":"https://www.wikidata.org/wiki/Q998803","display_name":"Tumor lysis syndrome","level":3,"score":0.4165000021457672},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4138999879360199},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41280001401901245},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.4011000096797943},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.3801000118255615},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3424000144004822},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.3100999891757965},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.29750001430511475},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.29260000586509705},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.2890999913215637},{"id":"https://openalex.org/C2777607303","wikidata":"https://www.wikidata.org/wiki/Q641307","display_name":"Immunodeficiency","level":3,"score":0.2838999927043915},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.2777000069618225},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2721000015735626},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.25040000677108765}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.3324/haematol.2026.301971","doi":"https://doi.org/10.3324/haematol.2026.301971","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2026.301971","pdf_url":"https://haematologica.org/article/download/14532/81121","source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},{"id":"pmid:42984405","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42984405","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:69e98280f41c4af1bd78effae498318c","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/69e98280f41c4af1bd78effae498318c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematologica, Vol 999, Iss 1 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3324/haematol.2026.301971","doi":"https://doi.org/10.3324/haematol.2026.301971","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2026.301971","pdf_url":"https://haematologica.org/article/download/14532/81121","source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225317898.pdf","grobid_xml":"https://content.openalex.org/works/W7225317898.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2606848713","https://openalex.org/W2952785646","https://openalex.org/W2038139667","https://openalex.org/W2095426672","https://openalex.org/W7204729238","https://openalex.org/W2907026908","https://openalex.org/W2980182281","https://openalex.org/W2737256505","https://openalex.org/W4411832223","https://openalex.org/W2159684338"],"abstract_inverted_index":{"Treatment":[0],"of":[1,15,33,104,115,124,152,163,200,204,214,226,243],"patients":[2],"with":[3,70,95,156],"B-cell":[4,140],"acute":[5],"lymphoblastic":[6],"leukemia":[7,55,63],"(B-ALL)":[8],"has":[9,57],"benefited":[10],"greatly":[11],"from":[12,183],"the":[13,78,102,136,150,176,189,212,241],"introduction":[14],"different":[16],"immunotherapy":[17,105],"approaches":[18],"targeting":[19],"CD19":[20],"or":[21,28,74],"CD22.":[22],"In":[23,193,230],"particular,":[24],"when":[25,29],"added":[26],"to":[27,130,144,170,173,210,219,236],"replacing":[30],"some":[31],"parts":[32],"chemotherapy":[34],"treatment,":[35],"blinatumomab,":[36,84,174],"a":[37,201],"bispecific":[38],"T-cell":[39],"engager":[40],"which":[41,117],"creates":[42],"an":[43,112],"immunological":[44],"synapse":[45],"between":[46],"patient's":[47],"CD3-expressing":[48],"T":[49],"lymphocytes":[50],"and":[51,68,93,135,165,218,224,248],"CD19-positive":[52],"cells,":[53],"including":[54],"blasts,":[56],"shown":[58,82,100],"unprecedented":[59],"efficacy":[60,81],"in":[61,65,87,91,107,147],"preventing":[62],"relapse/progression":[64],"both":[66],"adults":[67,92],"children":[69,94],"either":[71],"newly":[72,96],"diagnosed":[73,97],"relapsed":[75],"B-ALL.":[76],"Despite":[77],"great":[79],"anti-leukemia":[80],"by":[83,111],"data":[85],"obtained":[86],"large":[88],"randomized":[89],"studies":[90,185,238],"B-ALL":[98],"have":[99],"that":[101],"benefit":[103],"has,":[106],"part,":[108],"been":[109],"offset":[110],"increased":[113],"risk":[114],"infections,":[116],"can":[118],"even":[119],"occur":[120],"long":[121],"after":[122],"completion":[123],"immunotherapy.":[125],"Blinatumomab":[126],"is":[127,158,196],"also":[128],"able":[129],"lyse":[131],"normal":[132],"B":[133],"lymphocytes,":[134],"resulting":[137],"long-lasting,":[138],"profound":[139],"aplasia":[141],"may":[142],"lead":[143],"severe":[145],"hypogammaglobulinemia,":[146],"turn":[148],"increasing":[149],"incidence":[151],"infectious":[153],"complications.":[154],"Premedication":[155],"dexamethasone":[157],"widely":[159],"used":[160],"for":[161,222],"mitigation":[162],"neurotoxicity":[164],"other":[166],"systemic":[167],"toxicities":[168],"related":[169],"initial":[171],"exposure":[172],"but":[175],"dose":[177],"usually":[178],"employed":[179],"does":[180],"not":[181],"derive":[182],"well-conducted":[184],"aimed":[186],"at":[187],"identifying":[188],"recommended":[190],"steroid":[191],"dose.":[192],"addition,":[194,231],"there":[195],"no":[197],"robust":[198],"evidence":[199],"neuroprotective":[202],"effect":[203],"Dexamethasone.":[205],"This":[206],"Spotlight":[207],"Review":[208],"aims":[209],"highlight":[211],"importance":[213],"monitoring":[215],"immunoglobulin":[216,227],"levels":[217],"provide":[220],"guidelines":[221],"initiation":[223],"continuation":[225],"replacement":[228],"therapy.":[229],"we":[232],"focus":[233],"on":[234],"need":[235],"conduct":[237],"properly":[239],"addressing":[240],"identification":[242],"optimal":[244],"corticosteroid":[245],"doses,":[246],"regimens,":[247],"timing.":[249]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-06T00:00:00"}